Summary
In FY6/2026, the buy-and-resell model became established in the INVASE business. Revenue reached JPY 8,317M, roughly 2.9x the prior year, and quarterly operating income turned positive in 2H. The key question for 1Q FY6/2027 is whether the company can sell real estate inventory as planned and secure gross profit. That inventory had built up to JPY 1,328M at fiscal year-end. Management says the impact of MogeCheck's shift in monetization model had run its course by 3Q onward, so the year-ago comparison base is low. Combined profit from the two businesses needs to swing the year-ago operating loss of JPY 11M into the black. Achieving this would be the first indication of whether the full-year operating income target of JPY 371M (+67.0%) is on track. We also want to assess the capital efficiency of the debt-funded inventory build. A second watchpoint is the tax burden once the benefit from recognizing deferred tax assets falls away.
Key Points for Next Quarter
| Key Points & Focus | Implications |
|---|---|
INVASE GrowthYoY change in INVASE segment revenue, segment profit and number of contracts | Last year, revenue was JPY 7,066M and segment profit JPY 58M, a turnaround from a JPY -267M loss the year before. The pace of sales from the JPY 1,328M year-end inventory will determine the scale of 1Q revenue growth. |
MogeCheck RecoveryYoY change in MogeCheck segment revenue and segment profit | Last year, revenue was JPY 1,251M (-36.8%) and segment profit JPY 164M (-64.7%). The extent of the rebound from a year-ago base that includes the monetization shift will gauge the business's stability. |
Consolidated ProfitabilityWhether 1Q operating income turns positive; progress of recurring profit against the full-year plan | Year-ago operating income was JPY -11M, versus JPY +158M in the most recent 4Q (our estimate). How much of the 4Q profit level is sustained will shape confidence in the full-year plan (recurring profit of JPY 369M). |
Balance Sheet/InventoryQuarter-end balances of real estate for sale and interest-bearing debt | At last fiscal year-end, real estate for sale was JPY 1,328M, interest-bearing debt JPY 910M, and operating CF JPY -1,015M. The issue is whether inventory and borrowings are tracking in line with revenue scale. |
Tax Burden1Q income tax expense and quarterly net income | Last year, a deferred tax adjustment of JPY -95M lifted net income to JPY 308M (+92.8%), above recurring profit. This year's plan calls for net income growth of +19.3%, below recurring profit growth of +71.6%. We want to verify the underlying tax assumptions. |
Key Issues from Previous Results (FY6/2026 4Q Results)
FY6/2026 closed with revenue of JPY 8,317M (+185.0%) and operating income of JPY 222M (+12.7%). INVASE's swing to profit offset the profit decline at MogeCheck. The company's FY6/2027 plan calls for revenue of JPY 10,241M (+23.1%) and operating income of JPY 371M (+67.0%), implying faster profit growth. In 1Q, we will assess both how each business builds profit and how the balance sheet changes as inventory expands.
1. INVASE Business: Sustaining Revenue Growth and Securing Margins Under the Buy-and-Resell Model
- Prior Year: Revenue was JPY 7,066M (vs. JPY 936M the year before), and segment profit was JPY 58M, a turnaround from JPY -267M. Contracts totaled 678 (+97.7% YoY).
- This Year's Checkpoints: We will track 1Q sales progress on the JPY 1,328M of real estate for sale held at year-end, as well as per-property gross profit. Last year, a change in screening criteria at partner financial institutions temporarily delayed deals. Whether this continues to weigh on 1Q is another focus.
- Key Metrics: YoY change in INVASE segment revenue and segment profit; trend in the number of contracts.
2. MogeCheck Business: Revenue Recovery After Completing the Shift to Execution-Based Fees
- Prior Year: Revenue was JPY 1,251M (-36.8%) and segment profit JPY 164M (-64.7%). With advertising spend curtailed, user traffic was 7,928K (+3.6%) and user registrations 121K (-9.7%).
- This Year's Checkpoints: Management indicated the transition impact had run its course by 3Q onward, so the year-ago 1Q still includes that impact. We want to see whether normalized revenue recognition timing returns the segment to YoY revenue growth.
- Key Metrics: YoY change in MogeCheck segment revenue and segment profit; user traffic and user registrations.
3. Consolidated Profitability: 1Q Operating Profit and a Solid Start to the Full-Year Plan
- Prior Year: Quarterly operating income was JPY -11M in 1Q, -37M in 2Q, +112M in 3Q and +158M in 4Q, improving in 2H (our estimate). SG&A was held down to JPY 1,689M (-14.4%).
- This Year's Checkpoints: Gross profit margin fell to 23.0% as the buy-and-resell mix rose, so profitability should be judged on gross profit in absolute terms rather than margin. The key question is whether gross profit can grow while SG&A stays near the most recent 4Q level of JPY 373M (our estimate).
- Key Metrics: YoY change in 1Q operating income and recurring profit (year-ago: operating income JPY -11M, recurring profit JPY -7M); progress against the full-year recurring profit target of JPY 369M.
4. Balance Sheet: Inventory Build in Real Estate for Sale and Use of Borrowings
- Prior Year: Real estate for sale rose to JPY 1,328M from JPY 81M at the prior year-end. Interest-bearing debt was JPY 910M, operating CF JPY -1,015M, and the equity ratio 70.6%.
- This Year's Checkpoints: Simple inventory turnover days stood at 75.7 days (our estimate, based on consolidated cost of goods sold). The balance between expanded purchasing and sales is therefore a key issue. We will also check how much higher interest expense, JPY 10M last year, weighs on recurring profit as borrowings grow.
- Key Metrics: 1Q-end balances of real estate for sale, short-term borrowings, long-term borrowings, and cash and deposits; interest expense.
5. Net Income: Fading Deferred Tax Asset Benefit and Normalizing Tax Burden
- Prior Year: A deferred tax adjustment of JPY -95M brought total income taxes to JPY -93M. As a result, net income of JPY 308M exceeded recurring profit of JPY 215M. Deferred tax assets stood at JPY 129M (vs. JPY 33M at the prior year-end).
- This Year's Checkpoints: The company plans net income of JPY 368M against recurring profit of JPY 369M. Net income growth of +19.3% thus lags recurring profit growth of +71.6%. We want to confirm whether 1Q income tax expense is consistent with plan assumptions.
- Key Metrics: 1Q total income taxes; quarterly net income attributable to owners of parent company (year-ago: JPY -16M); EPS.
Key Timely Disclosures This Period
- 2026/10/29Launch of "MogeCheck Pro," a free mortgage proposal tool for real estate companies. This B2B channel initiative targets 1,000 companies in year one, rising to 10,000 real estate companies and 100 partner financial institutions within three years. The launch falls after 1Q-end, so there is no contribution to 1Q earnings. The checkpoint is its effect on user acquisition and referrals from 2Q onward.
- 2026/10/01Statutory post-transaction disclosure on the company split into Condominium Asset Management. This intra-group reorganization transfers the rights and obligations of the INVASE business to a wholly owned subsidiary. The direct impact on consolidated earnings should be limited; any operational efficiency gains will show up in segment profit from 2Q onward.
- 2026/09/30Matters Related to Business Plan and Growth Potential. This updated growth strategy disclosure followed the filing of the Annual Securities Report. At 1Q results, it will serve as the benchmark for comparing quarterly results against the KPI direction it sets out.
Previous Quarter Results (FY6/2026 Full-Year Results)
MFS,Inc. operates two segments: the MogeCheck business, a mortgage comparison and assessment service, and the INVASE business, which handles investment real estate. INVASE has completed its shift from a brokerage model to a buy-and-resell model. It has built an integrated service platform covering purchasing, sales and rental management. In FY6/2026, INVASE accounted for 85% of revenue, and the company positions it as the pillar driving group earnings. MogeCheck posted lower revenue and profit due to the monetization model shift and reduced advertising spend, but remained profitable. The company's FY6/2027 plan calls for revenue of JPY 10,241M and operating income of JPY 371M.
| Item | Amount | YoY | vs. Company Plan | Notes |
|---|---|---|---|---|
| Revenue | JPY 8,317M | +185.0% | - | Driven by INVASE business at JPY 7,066M |
| Operating Income | JPY 222M | +12.7% | - | Gross profit margin 23.0%; SG&A -14.4% |
| Recurring Profit | JPY 215M | +8.6% | - | Interest expense rose to JPY 10M |
| Net Income | JPY 308M | +92.8% | - | Deferred tax adjustment of JPY -95M |
| EPS | JPY 31.99 | +81.3% | - | - |
Achievement Rate vs. Full-Year Plan (Recurring Profit Basis): - (year-ago: -). Not calculated, as the company's FY6/2026 plan figures are not included in this earnings release.
ENVALITH, INC. ("ENVALITH") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.
- Purpose and Disclaimer Regarding Investment Decisions
This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and ENVALITH and subject company shall not be involved in any such investment decisions.
- Information Sources, Accuracy, and Disclaimer of Warranty
This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. ENVALITH has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by ENVALITH using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, ENVALITH and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. ENVALITH and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.
- Limitation of Liability
ENVALITH and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.
- Potential Conflicts of Interest
ENVALITH may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.
- No Obligation to Change or Update Content
The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that ENVALITH is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.
- Governing Language
This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.
- Copyright
All rights (including copyrights) relating to this report belong to ENVALITH. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of ENVALITH is strictly prohibited.
- Use for Other Investment Products
Except where ENVALITH has provided prior written approval, the use of this report and the trademarks or trade names of ENVALITH or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.